Secondary Bacterial Infections During Pulmonary Viral Disease: Phage Therapeutics as Alternatives to Antibiotics?

Secondary Bacterial Infections During Pulmonary Viral Disease: Phage Therapeutics as Alternatives to Antibiotics?

Secondary bacterial infections manifest during or after a viral infection(s) and can lead to negative outcomes and sometimes fatal clinical complications. Research and development of clinical interventions is largely focused on the primary pathogen, with research on any secondary infection(s) being...

Full description

Bibliographic Details
Main Authors: Prasanth Manohar, Belinda Loh, Sudarsanan Athira, Ramesh Nachimuthu, Xiaoting Hua, Susan C. Welburn, Sebastian Leptihn
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-06-01
Series:Frontiers in Microbiology
Subjects:
secondary bacterial infection
pulmonary viruses
SARS-CoV-2
COVID-19
phage therapy
phage endolysins
Online Access:https://www.frontiersin.org/article/10.3389/fmicb.2020.01434/full

Internet

https://www.frontiersin.org/article/10.3389/fmicb.2020.01434/full

Similar Items